Dan Hemming is an associate in the Los Angeles office of Latham & Watkins and a member of the Litigation & Trial Department.

As a member of the Intellectual Property Litigation Practice, Dan focuses on high-stakes patent litigation in the district court. He has experience spanning all phases of litigation, including pre-suit diligence, fact and expert discovery, claim construction, dispositive motions, trial, and post-trial briefing.

Dan’s work focuses on life sciences technologies. He has represented industry-leading companies in patent cases related to various technologies, including drug compounds and formulations, antibody-drug conjugates, and gene editing.

Dan received his JD from Georgetown University Law Center, where he served as an executive editor for the Journal of Law and Public Policy. He also holds a BS in molecular, cell, and developmental biology from UCLA.

Dan’s experiences includes representing:

  • Sarepta in a patent jury trial relating to exon-skipping antisense oligonucleotides for Duchenne Muscular Dystrophy
  • AbbVie in a Hatch-Waxman litigation involving Rinvoq®
     

Bar Qualification

  • California

Education

  • JD, Georgetown University Law Center, 2023
  • BS in Molecular, Cell, and Developmental Biology, University of California, Los Angeles, 2019